Navigation Links
Sensortech Announces New, Ligament Balancing TKA Smart Insert
Date:2/6/2013

PENDLETON, S.C., Feb. 6, 2013 /PRNewswire/ -- Sensortech Corporation announced advancement of their new, orthopedic knee alignment product, the Force Check Knee Replacement Smart Insert designed for improving total knee arthroplasty (TKA) surgeries.

Incorporating FDA-approved Bluetooth 4 low energy technology, and FDA-approved plastics technology, the Force Check Knee Replacement Smart Insert can readily adapt to all TKA replacement components on the market. The insert will increase TKA profitability through reduced operating and patient recovery times, faster healing times, reduced component wear, superior pain management and fewer revisions.

With FDA approval, Sensortech's technology could also become a "leave in" device, measuring TKA component performance throughout the replacement's operational life. 

 "The new Smart Insert is a patented, superior solution. It provides real time condyle contact pressure (force) as well as contact location and contact patch movement tracking throughout the flexion test—something unique to the market today. We know the demand for this device is there.  Surgeons and medical device manufacturers have been telling us they need our insert," said inventor Dr. Andrew Clark .

To exploit the market value of this device and assist in acquiring a 510K to develop the "leave in" solution, Sensortech is seeking acquisition partner(s).  The company has also positioned their Force Check Knee Replacement Smart Insert device as an initial entry into a line of medical device smart inserts for all types of joint replacement surgeries.  For more information about Sensortech go to www.sensortechknee.com or contact Sensor Tech Corporation at info@sensortechcorp.com, (864) 298-0684.

This press release includes forward-looking statements c
'/>"/>

SOURCE Sensortech Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Emerald Logic announces collaboration with Kings College London on quantitative biomarker discovery
2. Uroplasty Announces Executive Changes In US Sales Organization
3. Akorn, Inc. Announces Fourth Quarter 2012 Earnings Release And Conference Call Information
4. Blue Belt Technologies Announces Hiring of U.S. Commercial Leadership Team
5. Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil
6. MGC Diagnostics Corporation Announces National Jewish Health Selects the Company as Preferred Provider for Cardiopulmonary Diagnostic Instrumentation
7. Organovo Holdings, Inc. announces redemption of 2.9 million outstanding warrants
8. China Botanic Pharmaceutical Inc. Announces Receipt of Notice of Failure to Satisfy Continued Listing Requirements
9. BD Announces Results for 2013 First Fiscal Quarter
10. Hologic Announces First Quarter Fiscal 2013 Operating Results
11. Cyberonics Announces Update On Hagerty Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... , N.Y. and MEXICO CITY , ... today announced that PLM, a Latin American healthcare sciences ... to deliver medical information on conditions such as cancer ... can now access the most up-to-date information to deliver ... medical professionals is growing rapidly, with many relying on ...
(Date:7/25/2014)... , July 25, 2014  AMETEK, Inc. (NYSE: ... Kurtis L. Goos as Vice President and General ... and Packaging (EMIP) Division. "I am pleased ... management and business development experience, especially in the medical ... contributions to the continued growth and success of our ...
(Date:7/25/2014)... NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR ... JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF ... ABBV ) today announced financial results for the ... was another very strong quarter for AbbVie, as we delivered ... announced plans to merge with Shire, a strategic action that ...
Breaking Medicine Technology:Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 2Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 3Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 4AMETEK Names Kurtis L. Goos, Vice President & General Manager, Engineered Medical Components 2AbbVie Reports Second-Quarter 2014 Financial Results 2AbbVie Reports Second-Quarter 2014 Financial Results 3AbbVie Reports Second-Quarter 2014 Financial Results 4AbbVie Reports Second-Quarter 2014 Financial Results 5AbbVie Reports Second-Quarter 2014 Financial Results 6AbbVie Reports Second-Quarter 2014 Financial Results 7AbbVie Reports Second-Quarter 2014 Financial Results 8AbbVie Reports Second-Quarter 2014 Financial Results 9AbbVie Reports Second-Quarter 2014 Financial Results 10AbbVie Reports Second-Quarter 2014 Financial Results 11AbbVie Reports Second-Quarter 2014 Financial Results 12AbbVie Reports Second-Quarter 2014 Financial Results 13AbbVie Reports Second-Quarter 2014 Financial Results 14AbbVie Reports Second-Quarter 2014 Financial Results 15AbbVie Reports Second-Quarter 2014 Financial Results 16AbbVie Reports Second-Quarter 2014 Financial Results 17AbbVie Reports Second-Quarter 2014 Financial Results 18AbbVie Reports Second-Quarter 2014 Financial Results 19AbbVie Reports Second-Quarter 2014 Financial Results 20AbbVie Reports Second-Quarter 2014 Financial Results 21AbbVie Reports Second-Quarter 2014 Financial Results 22AbbVie Reports Second-Quarter 2014 Financial Results 23AbbVie Reports Second-Quarter 2014 Financial Results 24AbbVie Reports Second-Quarter 2014 Financial Results 25AbbVie Reports Second-Quarter 2014 Financial Results 26AbbVie Reports Second-Quarter 2014 Financial Results 27AbbVie Reports Second-Quarter 2014 Financial Results 28AbbVie Reports Second-Quarter 2014 Financial Results 29AbbVie Reports Second-Quarter 2014 Financial Results 30AbbVie Reports Second-Quarter 2014 Financial Results 31AbbVie Reports Second-Quarter 2014 Financial Results 32
... SEATTLE, March 25 Cell Therapeutics, Inc.,(CTI) (Nasdaq: ... complete in,the phase III EXTEND (PIX301) clinical trial of ... non-Hodgkin,s lymphoma (NHL).,An analysis of the data is expected ... with the U.S. Food and Drug Administration (FDA) the ...
... Patients to ... Higher Rates of BARACLUDE Resistance -, PRINCETON, N.J., ... a continued low incidence of,resistance in nucleoside-naive patients through ... patients analyzed, no additional,patient developed resistance in the fifth ...
Cached Medicine Technology:Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL 2Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL 3Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL 4BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 2BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 3BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 4BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 5BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 6
(Date:7/26/2014)... The North America Cyber Security report defines and ... with analysis and forecast of revenue. This market is ... to $33.24 billion by 2019, at a CAGR of ... TOC of the North America Cyber Security Market report ... It also provides a glimpse of the segmentation in ...
(Date:7/26/2014)... SATURDAY, July 26, 2014 (HealthDay News) -- Pools can ... can make themselves sick if they swallow too much ... excitement, it,s common for little ones to get water ... drink from a pool, despite warnings from their parents. ... is harmless, it,s important for parents to realize that ...
(Date:7/26/2014)... July 26, 2014 According ... updated by Vkool.com, this is a comprehensive ... methods for treating all types of ...     Tinnitus due to Ménière's disease ...     Nerve pathway tinnitus ,     Inner, ...
(Date:7/26/2014)... 2014 The U.S. Food & Drug Administration ... a new medication guide for AndroGel to include blood clots ... taking the topical low testosterone medication, notes Wright & Schulte ... makers of the low testosterone theapy drug, has also updated ... or redness as signs of a blood clot in the ...
(Date:7/26/2014)... According to the "Get Rid Tattoo ... a comprehensive guide that provides readers with safe and ... book also teaches them how to fade dark colored ... their own home for drastic results. , Vkool ... book includes step-by-step tutorials and product recommendations for treating ...
Breaking Medicine News(10 mins):Health News:North America Cyber Security Market is Expected to Reach $33 billion in 2019 - New Report by MicroMarket Monitor 2Health News:North America Cyber Security Market is Expected to Reach $33 billion in 2019 - New Report by MicroMarket Monitor 3Health News:North America Cyber Security Market is Expected to Reach $33 billion in 2019 - New Report by MicroMarket Monitor 4Health News:Don't Let Kids Drink Pool Water 2Health News:Tinnitus Miracle Book Review Exposes Thomas Coleman's Guide for Treating Tinnitus – Vkool.com 2Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 2Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 3Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 4Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 5Health News:"Get Rid Tattoo Naturally" Book Review Exposes Jason Carter's Tattoo Removal Guide – Vkool.com 2Health News:"Get Rid Tattoo Naturally" Book Review Exposes Jason Carter's Tattoo Removal Guide – Vkool.com 3
... , ORANGE COUNTY, Calif., Oct. 14 Beckman Coulter, Inc. ... conference call on Thursday, October 29, 2009, at 5:00 p.m. ... Earnings will be released after the market closes. , (Logo: ... by dialing (877) 516-3365 or (706) 679-3246 and asking for ...
... American Academy of Physician Assistants (AAPA), representing 75,000 ... States, applauds the Senate Finance Committee,s vote to ... is committed to seeking health care reform legislation ... quality, affordable, cost-effective health care. , "Physician ...
... Payment Would Cover Just Two Percent of Lost Income ... Security Administration is expected to announce that seniors will receive ... checks next year. , President Obama,s call late this ... for seniors would make up just a tiny fraction of ...
... Inc. magazine ranked Texas Physical Therapy Specialists ... an exclusive ranking of the nation,s fastest-growing private companies. The ... segment of the economy--America,s independent-minded entrepreneurs. , "If you want ... look at the Inc. 500," said Inc. editor Jane Berentson. ...
... received artificial kidney treatment: study , WEDNESDAY, Oct. 14 (HealthDay ... older Americans in nursing homes who suffer kidney failure in ... published in the Oct. 15 issue of the New ... to lengthen or improve most patients, lives. , "The hope ...
... ... and CEO of Atlanta-based Jackson Healthcare, proposed a radical plan to ... stage as the current administration spearheads an aggressive reform of the ... propaganda that have saturated the news, Jackson’s core argument remains as ...
Cached Medicine News:Health News:American Academy of Physician Assistants Applauds Senate Finance Committee for Advancing Health Reform Legislation 2Health News:Social Security COLA: Tomorrow's Zero COLA Announcement for 2010 Could Cost Average Senior $10,134 2Health News:Inc. Magazine Unveils 28th Annual List of America's Fastest-Growing Private Companies - the Inc. 500 2Health News:Dialysis' Drawbacks Outweigh Benefits for Some Older Patients 2Health News:Dialysis' Drawbacks Outweigh Benefits for Some Older Patients 3Health News:Restoring the Physician/Patient Relationship: An Interview with Jackson Healthcare's CEO 2Health News:Restoring the Physician/Patient Relationship: An Interview with Jackson Healthcare's CEO 3Health News:Restoring the Physician/Patient Relationship: An Interview with Jackson Healthcare's CEO 4Health News:Restoring the Physician/Patient Relationship: An Interview with Jackson Healthcare's CEO 5
... VICTOR2 V ... fluorescence polarization, luminescence, ... and absorbance. A ... LANCE assay. All ...
This is the modular VICTOR2 multilabel counter with the TR-fluorometry, stacker and robot loading options.The addition of a xenon flash lamp brings the time-resolved fluorescence counting mode to th...
This is the modular manually operated VICTOR2 multilabel counter, with the addition of a xenon flash lamp for time-resolved fluorescence counting. Along with this option comes flash absorbance and du...
... readers available today operate with either one, ... speed) or use an imaging process to ... sensitivity and the individual signals can overlap). ... miniature lens array containing 96 parallel micro-objectives. ...
Medicine Products: